Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
An open-label, follow-up study to evaluate the safety and efficacy of levetiracetam (LEV), in
children (≥ 4 years old), adolescents and adults suffering from primary generalized seizures.